Return to content in this issue
Severe Eosinophilic Allergic Asthma Responsive to Mepolizumab After Failure of 2 Consecutive Biologics
Sánchez-Jareño M1, Barranco P1,2, Romero D3, Domínguez-Ortega J1, Quirce S1,2
1Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
2CIBER de Enfermedades Respiratorias, Ciberes, Madrid, Spain
3Department of Pneumology, Hospital La Paz, Madrid, Spain
J Investig Allergol Clin Immunol 2019; Vol 29(1)
: 79-81
doi: 10.18176/jiaci.0340
Key words: Severe eosinophilic asthma, Biologics, Phenotypes, Biomarkers, Anti-IL-5 antibodies